Rtw Investments, LP Akero Therapeutics, Inc. Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 5,919,435 shares of AKRO stock, worth $305 Million. This represents 2.71% of its overall portfolio holdings.
Number of Shares
5,919,435
Previous 5,431,985
8.97%
Holding current value
$305 Million
Previous $127 Million
33.27%
% of portfolio
2.71%
Previous 2.13%
Shares
3 transactions
Others Institutions Holding AKRO
# of Institutions
191Shares Held
74.6MCall Options Held
241KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.9MShares$406 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$364 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$288 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$269 Million4.29% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.81MShares$196 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.39B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...